MIM Gets 510(k) Clearance for Its Molecular Radiotherapy Software

Cleveland, Ohio-based medical imaging company MIM Software has received the FDA’s 510(k) clearance for updates to its SurePlan MRT software for molecular radiotherapy.

The clearance covers new artificial intelligence (AI)-based segmentation modeling, which simplifies the process of measuring the radiation dose absorbed by the patient. The AI-based tool saves time and enhances results compared to manual analysis, the company said.  

The SurePlan MRT software, which received initial 510(k) clearance from the FDA in December 2018 and CE Mark certification in March 2020, can be deployed locally or through the cloud.